Amplify Weight Loss Drug & Treatment ETF Rating $22.20 +0.67 (+3.11%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.68Holdings in THNR have an aggregate rating of Moderate Buy based on 188 analyst ratings issued in the past year covering 14 companies (70.6% of the portfolio).THNR Aggregate Price Target$22.20High Prediction$22.20Average Prediction$22.20Low Prediction$22.20Holdings in THNR have an aggregate price target of $22.20 and a range of $22.20 to $22.20 covering 14 companies (70.6% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.38%LLYEli Lilly and Company$825.10+3.9%4.9236 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up13.89%NVONovo Nordisk A/S$69.27+5.6%4.7209 of 5 stars2.38$135.00 94.9%13Upcoming EarningsShort Interest ↑Gap UpHigh Trading Volume5.23%WSTWest Pharmaceutical Services$211.27+0.5%4.662 of 5 stars3.00$332.50 57.4%85.05%AMGNAmgen$281.22-0.9%4.1049 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up4.90%AZNAstraZeneca$72.44+2.7%2.9255 of 5 stars3.10$88.00 21.5%10Earnings ReportShort Interest ↓Analyst Revision4.84%TMOThermo Fisher Scientific$423.69+0.9%4.8799 of 5 stars2.81$607.43 43.4%21Analyst ForecastInsider TradeShort Interest ↑Positive NewsGap Up4.81%PFEPfizer$24.19+1.1%4.9812 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst ForecastAnalyst Revision4.56%TEVATeva Pharmaceutical Industries$16.22+3.8%3.1559 of 5 stars3.00$23.43 44.4%8Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsGap Up4.51%MRKMerck & Co., Inc.$83.14-0.1%5 of 5 stars2.59$111.13 33.7%22Insider TradeAnalyst RevisionPositive News3.70%HIMSHims & Hers Health$40.98+13.3%2.4578 of 5 stars2.08$36.92 -9.9%13Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading Volume1.78%GPCRStructure Therapeutics$27.09-0.9%2.4264 of 5 stars3.00$78.63 190.2%9Upcoming EarningsAnalyst ForecastNews CoverageGap Up1.51%VKTXViking Therapeutics$29.36+2.6%4.5331 of 5 stars3.00$87.15 196.8%14Analyst UpgradeOptions VolumeAnalyst RevisionGap Up0.26%OPKOPKO Health$1.39+2.6%4.4941 of 5 stars2.75$2.75 98.6%4Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.20%ALTAltimmune$5.77+11.6%2.4147 of 5 stars3.00$20.83 261.1%8Upcoming EarningsNews Coverage This page (NYSEARCA:THNR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THNR Stock Free THNR Stock Alerts